Dermatology and Therapy

In this study, authors investigate and quantify the contributions of different factors affecting diagnostic delay in #HidradenitisSuppurativa from the perspective of improving healthcare system equity: link.springer.com/article/10.100…

This study aimed to evaluate the #efficacy and tolerability of a novel dermo-cosmetic α-AZ cream (Teen Derm® A.Z cream) when used alone or in combination with oral antibiotics for the treatment of mild to moderate #acne: link.springer.com/article/10.100… #AzelaicAcid #Therapy

This systematic literature review and network meta-analysis aimed to evaluate the 1-year #efficacy and #safety of #bimekizumab versus other biologic systemic therapies for moderate to severe plaque #psoriasis: link.springer.com/article/10.100…

The aim of this study was to assess the efficacy and safety of a fixed-dose combination gel with adapalene 0.1% and clindamycin 1% relative to adapalene 0.1% monotherapy and clindamycin 1% monotherapy in patients with moderate facial #acne vulgaris: link.springer.com/article/10.100…

The objective of the current study was to determine the cost-effectiveness of #difamilast 1% compared with #delgocitinib 0.5% in Japanese adult patients with moderate-to-severe #AtopicDermatitis and compared with placebo in Japanese adult patients: link.springer.com/article/10.100…

Passionate about dermatology and love podcasting? Submit your podcast to our journal! Help us spread skin science knowledge in a fun and accessible way. #Dermatology #Podcast #Dermtherapy #PodcastSubmission

In this study authors conducted a survey to explore patient and dermatology HCP perspectives on #SeborrheicDermatitis treatment preferences, experiences, and unmet needs, aiming to understand the physical and emotional burden of the condition: link.springer.com/article/10.100…

#Acne is the most frequent chronic inflammatory skin condition in adolescence but occurs also in later age. In this study, authors aim to characterise the epidemiology, geographical distribution, comorbidity and healthcare of acne juvenilis and acne tarda: link.springer.com/article/10.100…

Just published: #Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe: link.springer.com/article/10.100…

This randomized #phase3 study aimed to evaluate the long-term efficacy and tolerability of V0034CR, an emollient that combines the moisturizing and barrier-repairing properties of glycerol with the anti-irritant and occlusive properties of paraffin. link.springer.com/article/10.100…

The Hand Eczema Impact Scale s a new patient-reported outcome (PRO) measure designed to assess the impact of #ChronicHandEczema on key domains of HRQoL. This study aimed to develop and evaluate content and psychometric validity of this: link.springer.com/article/10.100…

Exciting news! 📈 Our journal’s new metrics are in: Impact Factor 3.5, CiteScore 6.0, h-index 46, and 1,500 downloads. Thank you for your continued support and engagement! 🌟 #JournalMetrics #ResearchImpact #Dermatologyandtherapy

The disposal of regulated medical waste in the healthcare setting can be both costly and environmentally harmful. Few studies to date have investigated the efficacy of waste reduction practices in the #dermatology setting. This study aimed to investigate! shorturl.at/5Hlnx

This study aimed to determine the proportion of patients by severity and compare the clinical #efficacy and #safety of #difamilast with #delgocitinib among patients with moderate-to-severe #AtopicDermatitis using a matching-adjusted indirect comparison: link.springer.com/article/10.100…

Want to know how lebrikizumab stacks up against tralokinumab and cendakimab? Find more details on our comparative study of binding affinities and functional activities in the paper! shorturl.at/4IYam 🌟🔬 #Research #AtopicDermatitis #Lebrikizumab #Tralokinumab #Cendakimab

This study aimed to determine the proportion of patients by severity and compare the clinical efficacy and safety of #difamilast with #delgocitinib among patients with moderate-to-severe #AtopicDermatitis using a matching-adjusted indirect comparison: link.springer.com/article/10.100…

This newly published post hoc analysis explored efficacy and safety of 1.5% #ruxolitinib cream by previous medication use. Read this in full here: link.springer.com/article/10.100…

In this latest study, experts assess the #efficacy and #safety of #risankizumab in patients with moderate-to-severe plaque #psoriasis by race and ethnicity in the open label extension LIMMitless (NCT03047395): link.springer.com/article/10.100…

Advanced Systemic Treatments in Patients with Moderate-to-Severe Atopic Dermatitis: Key Learnings from Physicians Practicing in Nine Asian Countries and Territories: link.springer.com/article/10.100…

What are the similarities and differences in how patients, caregivers, and physicians perceive the burden of atopic dermatitis? Discover insights from our top downloaded paper, the AD-GAP survey! shorturl.at/5PgyP 🌿📊 #AtopicDermatitis #TopPaper #DermatologyandTherapy